JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walters, P. A.
Right arrow Articles by Green, H. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Walters, P. A., Jr.
Right arrow Articles by Green, H. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 114, Issue 3, 323-328, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


DILATOR RESPONSES TO ISOPROTERENOL IN CUTANEOUS AND SKELETAL MUSCLE VASCULAR BEDS; EFFECTS OF ADRENERGIC BLOCKING DRUGS

Paul A. Walters Jr. 1, Thomas W. Cooper 1, Adam B. Denison Jr. 1, and Harold D. Green 1

1 Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest College, Winston-Salem, N. C.

By means of the electromagnetic flowmeter, the vasomotor responses to intra-arterial injections of isoproterenol were compared to those of epinephrine and levarterenol in cutaneous and skeletal muscle vascular beds before and during blockade with azapetine (Ilidar) and phenoxybenzamine (Dibenzyline).

Isoproterenol caused vasodilation in both beds.

In skin, the dilator respotises to isoproterenol were blocked by approximately the same dose as that which blocked the constrictor responses to epinephrine and levarterenol, i.e., 10 mgm./kgm. of phenoxybenzamine and 30 mgm./kgm. of azapetine.

In muscle, the dilator responses to isoproterenol were blocked at the same dose that abolished the dilator responses to epinephrine, i.e., 1 mgm./kgm. of phenoxybenzamine and 60 mgm./kgm. of azapetine. These were approximately 20 times the dose required to block the constrictor responses to levarterenol.

It was suggested that epinephrine behaves as if it were a composite of both levarterenol and isoproterenol.

Submitted on June 28, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.